Inhibition of steroidogenesis in rat adrenal cortex cells by a threonine analogue

• Published in: The Journal of steroid biochemistry and molecular biology Vol. 40; no. 1-3; p. 421
• Main Authors: Green, E G, Orme-Johnson, N R
• Format: Journal Article
• Language: English
• Published: England 1991
• Subjects: Adrenal Cortex - cytology; Adrenal Cortex - metabolism; Adrenocorticotropic Hormone - physiology; Animals; Corticosterone - biosynthesis; Female; Phosphorylation; Rats; Rats, Inbred Strains; Serine - metabolism; Steroids - antagonists & inhibitors; Steroids - biosynthesis; Threonine - analogs & derivatives; Threonine - metabolism; Threonine - pharmacology
• ISSN: 0960-0760
• DOI: 10.1016/0960-0760(91)90211-M

We have investigated the ability of amino acid analogues of serine and threonine to inhibit the increase in steroidogenesis elicited by addition of ACTH or cAMP in cells isolated from the rat adrenal cortex. We have found that the serine analogues, D, L-isoserine, alpha-methyl-D, L-serine and L-homoserine, are almost totally ineffective in inhibiting this process but that the threonine analogue, D, L-beta-hydroxynorvaline, at a concentration of 300 microM inhibits stimulated steroid hormone biosynthesis by ca 95%, while inhibiting overall protein synthesis by only ca 40%. This inhibition was found to occur in a dose-dependent manner and to be reversible by a stoichiometric concentration of threonine. These studies suggest that beta-hydroxynorvaline is functioning as a threonine analogue in our experimental system. Both the onset of inhibition by analogue and reversal of this inhibition by the natural amino acid occurred rapidly, without detectable lag. Since results obtained using cAMP as stimulant parallel those obtained using ACTH, the inhibitory effect of the analogue seems to occur subsequent to the synthesis of cAMP. Additionally, the analogue does not inhibit the conversion of pregnenolone to corticosterone, suggesting the site of action of analogue occurs prior to the synthesis of pregnenolone from cholesterol. Thus, the analogue may be exerting its effect on a protein that is synthesized subsequent to ACTH addition and is important in the acute phase of stimulated steroid hormone biosynthesis. Further, since ACTH action on adrenal cortex cells causes the activation of protein kinase A, which phosphorylates serine and threonine residues, it is possible that the effect of the analogue is to prevent the phosphorylation of a newly-synthesized protein.